(Q52761553)

7 May 2018

title

JAUNDICE AND ITS RELATION TO THERAPEUTIC AGENTS. (English)

1 reference

7 May 2018

author name string

G C COOK

series ordinal

1

1 reference

7 May 2018

S SHERLOCK

series ordinal

2

1 reference

7 May 2018

language of work or name

English

0 references

publication date

1 January 1965

1 reference

7 May 2018

published in

The Lancet

1 reference

7 May 2018

volume

1

1 reference

7 May 2018

issue

7378

1 reference

7 May 2018

page(s)

175-179

1 reference

7 May 2018

Chlorpromazine: ten years' experience

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Serial liver-function and blood studies in patients receiving chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Significance of abnormally low blood urea levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Hepatitis caused by the newer amine-oxidase-inhibiting drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Allergy to chlorpromazine manifested by jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Jaundice associated with the administration of iproniazid; report of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

HALOTHANE AND LIVER DYSFUNCTION: A RETROSPECTIVE STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Pathological findings in jaundice associated with iproniazid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Drug-induced hepatic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Hepatocellular Jaundice as a Complication of Iproniazid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Pathogenesis and management of hepatic coma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

POSTOPERATIVE HEPATIC NECROSIS. ITS INCIDENCE AND DIAGNOSTIC VALUE IN ASSOCIATION WITH THE ADMINISTRATION OF HALOTHANE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Neurological Complications of Infective Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Hepatic dysfunction due to chlorpromazine hypertensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Cholestasis due to prochlorperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Liver cell necrosis in chlorpromazine jaundice (allergic cholangiolitis). A serial study of twenty-six needle biopsy specimens in nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

Liver damage concurrent with iproniazid administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2865%2990969-4

7 January 2021

10.1016/S0140-6736(65)90969-4

Identifiers

DOI

1 reference

7 May 2018

PubMed ID

14238042

1 reference

7 May 2018